Lexaria Bioscience (LEXX) Earnings Date & Reports

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LEXX is expected to report earnings to fall 25.00% to -5 cents per share on October 28

Lexaria Bioscience LEXX Stock Earnings Reports

Q3'26

Est.

$-0.06

Q2'26

Missed

by $0.02

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.07

Q3'25

Beat

by $0.02

The last earnings report on July 31 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 306.69K shares outstanding, the current market capitalization sits at 9.69M.

View a ticker or compare two or three

LEXX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days